Costanza Bogani

2.2k total citations
32 papers, 1.3k citations indexed

About

Costanza Bogani is a scholar working on Genetics, Rheumatology and Hematology. According to data from OpenAlex, Costanza Bogani has authored 32 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Genetics, 14 papers in Rheumatology and 13 papers in Hematology. Recurrent topics in Costanza Bogani's work include Myeloproliferative Neoplasms: Diagnosis and Treatment (27 papers), Eosinophilic Disorders and Syndromes (13 papers) and Chronic Myeloid Leukemia Treatments (8 papers). Costanza Bogani is often cited by papers focused on Myeloproliferative Neoplasms: Diagnosis and Treatment (27 papers), Eosinophilic Disorders and Syndromes (13 papers) and Chronic Myeloid Leukemia Treatments (8 papers). Costanza Bogani collaborates with scholars based in Italy, United States and France. Costanza Bogani's co-authors include Alessandro M. Vannucchi, Paola Guglielmelli, Alberto Bosi, Alessandro Pancrazzi, Elisabetta Antonioli, Vanessa Ponziani, Lorenzo Tozzi, Niccolò Bartalucci, Giovanni Longo and Lisa Pieri and has published in prestigious journals such as Blood, PLoS ONE and Cancer Research.

In The Last Decade

Costanza Bogani

32 papers receiving 1.3k citations

Peers

Countries citing papers authored by Costanza Bogani

Since Specialization

Citations

This map shows the geographic impact of Costanza Bogani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Costanza Bogani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Costanza Bogani more than expected).

Fields of papers citing papers by Costanza Bogani

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Costanza Bogani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Costanza Bogani. The network helps show where Costanza Bogani may publish in the future.

Co-authorship network of co-authors of Costanza Bogani

This figure shows the co-authorship network connecting the top 25 collaborators of Costanza Bogani. A scholar is included among the top collaborators of Costanza Bogani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Costanza Bogani. Costanza Bogani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Tetraspanin CD9 participates in dysmegakaryopoiesis and stromal interactions in primary myelofibrosis 2015 ·Haematologica ·Christophe Desterke, Christophe Martinaud, Bernadette Guerton, Lisa Pieri, Costanza Bogani, Denis Clay, Fréderic Torossian, Jean‐Jacques Lataillade, (unknown), Heinz Gisslinger, JL Demory, Brigitte Dupriez, Claude Boucheix, Eric Rubinstein, (unknown), A. M. Vannucchi, Marie‐Caroline Le Bousse‐Kerdilès	6
2	Evaluation of plitidepsin in patients with primary myelofibrosis and post polycythemia vera/essential thrombocythemia myelofibrosis: results of preclinical studies and a phase II clinical trial 2015 ·Blood Cancer Journal ·Animesh Pardanani, Ayalew Tefferi, Paola Guglielmelli, Costanza Bogani, Niccolò Bartalucci, José Rodríguez, (unknown), (unknown), Vicente Alfaro, Alessandro M. Vannucchi	7
3	Co‐targeting the PI3K/ mTOR and JAK2 signalling pathways produces synergistic activity against myeloproliferative neoplasms 2013 ·Journal of Cellular and Molecular Medicine ·Niccolò Bartalucci, Lorenzo Tozzi, Costanza Bogani, Serena Martinelli, Giada Rotunno, Jean‐Luc Villeval, Alessandro M. Vannucchi	77
4	Targeted cancer exome sequencing reveals recurrent mutations in myeloproliferative neoplasms 2013 ·Leukemia ·(unknown), Elena Tenedini, Isabella Bernardis, Valentina Artusi, Lucia Artuso, Enrica Roncaglia, Paola Guglielmelli, Lisa Pieri, Costanza Bogani, Flavia Biamonte, Giada Rotunno, C Mannarelli, Elisa Bianchi, Alessandro Pancrazzi, Tiziana Fanelli, Guidantonio Malagoli Tagliazucchi, Sérgio Ferrari, Rossella Manfredini, Alessandro M. Vannucchi, Enrico Tagliafico	58
5	Preclinical Models for Drug Selection in Myeloproliferative Neoplasms 2013 ·Current Hematologic Malignancy Reports ·Niccolò Bartalucci, Costanza Bogani, Alessandro M. Vannucchi	2
6	The PI3K Specific Inhibitor BKM120 Results Effective and Synergizes With Ruxolitinib In Preclinical Models Of Myeloproliferative Neoplasms 2013 ·Blood ·Niccolò Bartalucci, Costanza Bogani, Serena Martinelli, Carmela Mannarelli, Jean‐Luc Villeval, Alessandro M. Vannucchi	1
7	mTOR Inhibitors Alone and in Combination with JAK2 Inhibitors Effectively Inhibit Cells of Myeloproliferative Neoplasms 2013 ·PLoS ONE ·Costanza Bogani, Niccolò Bartalucci, Serena Martinelli, Lorenzo Tozzi, Paola Guglielmelli, Alberto Bosi, Alessandro M. Vannucchi, (unknown)	79
8	Overexpression of microRNA-16-2 contributes to the abnormal erythropoiesis in polycythemia vera 2011 ·Blood ·Paola Guglielmelli, Lorenzo Tozzi, Costanza Bogani, Ilaria Iacobucci, Vanessa Ponziani, Giovanni Martinelli, Alberto Bosi, Alessandro M. Vannucchi	27
9	Epigenetic therapy in myeloproliferative neoplasms: evidence and perspectives 2009 ·Journal of Cellular and Molecular Medicine ·Alessandro M. Vannucchi, Paola Guglielmelli, Alessandro Rambaldi, Costanza Bogani, Tiziano Barbui	21
10	The JAK2V617 mutation induces constitutive activation and agonist hypersensitivity in basophils from patients with polycythemia vera 2009 ·Haematologica ·Lisa Pieri, Costanza Bogani, Paola Guglielmelli, Maria Zingariello, (unknown), Niccolò Bartalucci, Alberto Bosi, Alessandro M. Vannucchi	51
11	Generating Set Search Methods for Piecewise Smooth Problems 2009 ·SIAM Journal on Optimization ·Costanza Bogani, (unknown), Alessio Papini	4
12	Mitochondrial Expression and Functional Activity of Breast Cancer Resistance Protein in Different Multiple Drug-Resistant Cell Lines 2009 ·Cancer Research ·Michela Solazzo, Ornella Fantappiè, Massimo D’Amico, Chiara Sassoli, Alessia Tani, Greta Cipriani, Costanza Bogani, Lucia Formigli, Roberto Mazzanti	51
13	Generalized Pattern Search methods for a class of nonsmooth optimization problems with structure 2008 ·Journal of Computational and Applied Mathematics ·Costanza Bogani, (unknown), Alessio Papini	36
14	Constitutively Activated and Hyper-Sensitive Basophils in Patients with Polycythemia Vera: Role of JAK2V617F Mutation and Correlation with Pruritus 2008 ·Blood ·Alessandro M. Vannucchi, Lisa Pieri, Costanza Bogani, Paola Guglielmelli, Maria Zingariello, Rosa Alba Rana, Alberto Bosi	3
15	MicroRNA expression profile in granulocytes from primary myelofibrosis patients 2007 ·Experimental Hematology ·Paola Guglielmelli, Lorenzo Tozzi, Alessandro Pancrazzi, Costanza Bogani, Elisabetta Antonioli, Vanessa Ponziani, G Poli, Roberta Zini, Sérgio Ferrari, Rossella Manfredini, Alberto Bosi, Alessandro M. Vannucchi	61
16	Prospective identification of high-risk polycythemia vera patients based on JAK2V617F allele burden 2007 ·Leukemia ·Alessandro M. Vannucchi, Elisabetta Antonioli, Paola Guglielmelli, Giovanni Longo, Alessandro Pancrazzi, Vanessa Ponziani, Costanza Bogani, Pierluigi Rossi Ferrini, Alessandro Rambaldi, Vittoria Guerini, Alberto Bosi, Tiziano Barbui	279
17	Influence of JAK2V617F allele burden on phenotype in essential thrombocythemia 2007 ·Haematologica ·Elisabetta Antonioli, Paola Guglielmelli, G Poli, Costanza Bogani, Alessandro Pancrazzi, Giovanni Longo, Vanessa Ponziani, Lorenzo Tozzi, Lisa Pieri, Valeria Santini, Alberto Bosi, Alessandro M. Vannucchi	119
18	A quantitative assay for JAK2V617F mutation in myeloproliferative disorders by ARMS-PCR and capillary electrophoresis 2006 ·Leukemia ·Alessandro M. Vannucchi, Alessandro Pancrazzi, Costanza Bogani, Elisabetta Antonioli, Paola Guglielmelli	54
19	Molecular Profiling of CD34+ Cells in Idiopathic Myelofibrosis Identifies a Set of Disease-Associated Genes and Reveals the Clinical Significance of Wilms' Tumor Gene 1 (WT1) 2006 ·Stem Cells ·Paola Guglielmelli, Roberta Zini, Costanza Bogani, Simona Salati, Alessandro Pancrazzi, Elisa Bianchi, Francesco Mannelli, Sérgio Ferrari, Marie‐Caroline Le Bousse‐Kerdilès, Alberto Bosi, Giovanni Barosi, Anna Ritá Migliaccio, Rossella Manfredini, Alessandro M. Vannucchi	99
20	Abnormalities of GATA-1 in Megakaryocytes from Patients with Idiopathic Myelofibrosis 2005 ·American Journal Of Pathology ·Alessandro M. Vannucchi, Alessandro Pancrazzi, Paola Guglielmelli, Simonetta Di Lollo, Costanza Bogani, Gianna Baroni, Lucia Bianchi, Anna Ritá Migliaccio, Alberto Bosi, Francesco Paoletti	58

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact